TLDR
- CEO Jason Hollar sold 124,529 CAH stock for $29.4 million on Aug. 18, his first open-market sale since August 2025
- Total insider selling across top executives reached nearly $60 million in the days following earnings
- CAH hit a record close of $240.26 on Aug. 11 after Q4 EPS of $2.91 beat the $2.42 consensus estimate
- Stock has since pulled back, opening at $229.48 on Friday, down from a session high of $258.30
- Analysts maintain a “Moderate Buy” consensus with an average price target of $266.56
Cardinal Health CEO Jason Hollar sold $29.4 million worth of CAH stock on Aug. 18, just days after the company posted record gains following a strong earnings report. The stock hit a record close of $240.26 on Aug. 11, and reached an intraday high of $258.30.
The sales were executed at prices between $234.07 and $238.065 per share. This was Hollar’s first open-market sale since August 2025 and only his second stock sale since joining Cardinal in 2020.
Hollar was not alone. A wave of insider selling swept through the executive team the same day, pushing total sales to nearly $60 million.
CFO Aaron Alt sold 42,000 shares for over $9.9 million. Chief Legal and Compliance Officer Jessica Mayer sold 29,436 shares for nearly $7 million. Chief Information Officer Michelle Greene sold 11,650 shares for $2.7 million.
Segment CEOs Also Sold
The heads of Cardinal’s two main business units also trimmed their positions. Debbie Weitzman, CEO of the pharmaceutical unit, sold 7,354 shares for around $1.7 million. Steve Mason, CEO of the global medical products and distribution segment, sold 35,000 shares for around $8.3 million, cutting his ownership stake by nearly 66%.
Chief Accounting Officer Mary Scherer sold 2,302 shares for around $546,472 on Aug. 19. In total, insiders sold 210,271 shares worth nearly $49.6 million in the last quarter.
The selling came after Cardinal’s Q4 earnings report on Aug. 11 delivered a clear beat. EPS came in at $2.91, well ahead of the $2.42 consensus estimate. Revenue rose 5.8% year over year to $63.67 billion, though it came in short of the $65.15 billion analyst estimate.
The company also set FY2027 EPS guidance at $12.40 to $12.60, which helped fuel the initial stock surge. Analysts currently expect full-year EPS of $12.54.
Analysts Stay Bullish
Despite the pullback and insider selling, Wall Street remains largely positive on the stock. TD Cowen raised its price target to $280 and maintained a “buy” rating. Leerink Partners set a $292 price target. Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 target.
JPMorgan raised its target from $215 to $260 but kept a “neutral” rating. Sixteen analysts rate the stock a buy, three hold. The average price target sits at $266.56.
CAH opened at $229.48 on Friday, down from its post-earnings high. The 12-month low is $145.87. Cardinal also declared a quarterly dividend of $0.5158 per share, payable Oct. 15 to shareholders of record as of Oct. 1, representing a 0.9% yield.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
